Jorge Puelles

takeda development centre europe ltd.

H指数:15

被引数:595

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial

基于ARCAＤIA 1期3临床试验数据开发特应性皮炎的概念性疾病模型

Dermatology and Therapy

IF4.2

2026-09-220

OAAI

Patient preferences for prurigo nodularis treatment: a discrete choice experiment

结节性痒疹治疗患者的偏好：一项离散选择实验

Journal of Dermatological Treatment

IF3.9

2026-08-100

OAAI

A Conceptual Disease Model of Symptoms and Impacts in Adults with Prurigo Nodularis: A Qualitative and Literature-Informed Study

结节性痒疹成人症状与影响的概念疾病模型：一项定性研究与文献参考研究

Dermatology and Therapy

IF4.2

2026-03-070

OAAI

Comparing the Efficacy and Safety of Nemolizumab Versus Anti-interleukin Monoclonal Antibody Therapies in Combination with Topical Treatments for Moderate-to-Severe Atopic Dermatitis Using Network Meta-analysis

Dermatology and Therapy

IF4.2

2026-01-190

OAAI

Patient Insights on Acne Hyperpigmentation, Trifarotene, and Skincare: 6-Month, LEAP Phase 4 Qualitative Exit Interview Findings

痤疮色素沉着、三氟拉索和他克莫司：6个月LEAP第4阶段定性退出访谈发现

The Patient - Patient-Centered Outcomes Research

IF0

2025-11-240

OAAI

Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA)

特应性皮炎及nemolizumab治疗的患者体验：一项嵌入在3期临床试验（ARCAEDIA）中的试验内访谈研究

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH

IF3.1

2025-05-130

OAAI

Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis

DERMATOLOGY AND THERAPY

IF4.2

2025-04-010

OAAI

Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis

中度至重度特应性皮炎患者受试者睡眠日记的心理测量学验证

DERMATOLOGY AND THERAPY

IF4.2

2025-03-010

OAAI

Understanding patient and physician preferences when choosing between biologic and oral systemic treatment options for moderate-to-severe atopic dermatitis: a discrete choice experiment

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-080

PRE

Patient Perspectives on Living With Severe Prurigo Nodularis

JAMA DERMATOLOGY

IF11

2023-11-014

OAAI

Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials

DERMATOLOGY AND THERAPY

IF4.2

2023-09-253

OAAI

Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis

DERMATOLOGY AND THERAPY

IF4.2

2023-08-244

OAAI

The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis

DERMATOLOGY AND THERAPY

IF4.2

2023-06-176

OAAI

An explanatory sequential mixed-methods design to establish thresholds of within-individual meaningful change on a sleep disturbance numerical rating scale score in atopic dermatitis

QUALITY OF LIFE RESEARCH

IF2.7

2022-11-221

OAAI

Epidemiology of prurigo nodularis in England: a retrospective database analysis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2022-05-0922

OAAI

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2021-11-1717

OAAI

Early-stage Mycosis Fungoides: Epidemiology and Prognosis

早期蕈样肉芽肿: 流行病学和预后

ACTA DERMATO-VENEREOLOGICA

IF3.7

2020-01-0130

OAAI

The American neurogastroenterology and motility society gastroparesis cardinal symptom index-daily diary (ANMS GCSI-DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis

NEUROGASTROENTEROLOGY AND MOTILITY

IF2.9

2019-02-0716

PREAI

Early-stage mycosis fungoides: incidence and differential survival

EUROPEAN JOURNAL OF CANCER

IF7.1

2019-01-010

PREAI

Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis

DIABETES OBESITY & METABOLISM

IF5.7

2018-06-0416

OAAI

Jorge Puelles

个人简介

教育背景

工作经历

荣誉奖项

研究方向